Xiangxue Pharmaceutical Co.,Ltd. (300147.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
Sector
Healthcare
Industry
Biotechnology
Employees
2644
First IPO Date
December 15, 2010
| Name | Title | Pay | Year Born |
| Feng Lu | Director of Internal Audit & Financial Director | 0 | 1973 |
| Guanghua Tan | General Manager of Marketing Center | 0 | 1978 |
| Junliang Zhong | General Manager of Supply Chain | 0 | 1972 |
| Li Xu | Secretary of the Board of Directors & Non-Independent Director | 0 | 1987 |
| Zhiying Kang | GM of Technology R&D | 0 | 1977 |
| Runxi Liu | Accounting Supervisor | 0 | N/A |
| Yonghui Wang | Chairman & GM | 0 | 1962 |
| Lun Zeng | Vice President | 0 | 1969 |
Xiangxue Pharmaceutical Co., Ltd. is actively involved in the full pharmaceutical lifecycle within China, from scientific research and product development to sourcing, production, and market distribution. The company's product portfolio notably includes its branded Xiangxue antivirotic oral liquids. Beyond these pharmaceutical offerings, it also provides a variety of healthcare supplements and comprehensive wellness solutions, such as specialized food and beverage items. Xiangxue Pharmaceutical has forged a strategic alliance with 111, Inc., with the aim of advancing an "Internet + Medicine" framework tailored for China's traditional Chinese medicine industry. The firm was established in 1997 and its main operations are based in Guangzhou, China.